Pharmacogenomic Analysis of Combined Therapies against Glioblastoma Based on Cell Markers from Single-Cell Sequencing

Glioblastoma is the most common and aggressive form of primary brain cancer and the lack of viable treatment options has created an urgency to develop novel treatments. Personalized or predictive medicine is still in its infancy stage at present. This research aimed to discover biomarkers to inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junying, Wu, Ruixin, Yuan, Shouli, Kelleher, Robbie, Chen, Siying, Chen, Rongfeng, Zhang, Tao, Obaidi, Ismael, Sheridan, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675611/
https://www.ncbi.nlm.nih.gov/pubmed/38004399
http://dx.doi.org/10.3390/ph16111533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675611/
https://www.ncbi.nlm.nih.gov/pubmed/38004399
http://dx.doi.org/10.3390/ph16111533

Ejemplares similares